{"gene":"PTMA","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1986,"finding":"Human prothymosin alpha (PTMA) was cloned from cDNA libraries and shown to encode a highly acidic 111-amino-acid protein with no N-terminal signal peptide. PTMA mRNA is induced >15-fold upon mitogen stimulation of resting lymphocytes and similarly elevated by serum restitution in serum-deprived NIH 3T3 cells, establishing a direct link between PTMA expression and cell proliferation.","method":"cDNA cloning, sequencing, Northern blot, mitogen stimulation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 foundational cloning with multiple orthogonal methods; replicated in multiple cell types in same study","pmids":["3467312"],"is_preprint":false},{"year":2003,"finding":"Prothymosin alpha (ProT) negatively regulates caspase-9 activation by inhibiting apoptosome formation at physiological dATP concentrations. This was identified via biochemical fractionation and a small-molecule activator (PETCM) approach; RNAi-mediated elimination of ProT sensitized cells to UV-induced apoptosis and eliminated the requirement for PETCM in caspase activation. PHAP proteins (tumor suppressors) and ProT (oncoprotein) thus constitute opposing regulators of mitochondria-initiated caspase activation.","method":"Biochemical fractionation, high-throughput screening with PETCM, caspase activation assays, RNAi knockdown, UV-induced apoptosis assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2; multiple orthogonal methods (fractionation, chemical genetics, RNAi, functional apoptosis assays) in a single rigorous study; highly cited foundational paper","pmids":["12522243"],"is_preprint":false},{"year":2005,"finding":"PTMA (prothymosin alpha) directly interacts with Keap1, the cytoplasmic inhibitor of transcription factor Nrf2. PTMA competes with Nrf2 for binding to the same domain of Keap1 in vitro, thereby liberating Nrf2 from its inhibitory complex. In vivo, PTMA levels positively correlate with Nrf2-dependent transcription of oxidative stress-protecting genes. Keap1 was shown to be a nuclear-cytoplasmic shuttling protein with a nuclear export signal critical for its inhibitory action.","method":"Yeast two-hybrid screen, in vitro pulldown/competition assay, in vivo co-immunoprecipitation, overexpression and mRNA interference, reporter assays for Nrf2-dependent transcription","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2; yeast two-hybrid discovery confirmed by in vitro direct interaction assay and in vivo functional correlation with multiple methods","pmids":["15657435"],"is_preprint":false},{"year":2005,"finding":"RNA-binding protein HuR binds the PTMA (ProTalpha) mRNA and promotes its cytoplasmic translocation and translation, thereby exerting an antiapoptotic effect. Upon UV treatment, ProTalpha mRNA association with HuR on heavy polysomes increased dramatically. HuR overexpression increased ProTalpha translation and protein levels, while HuR knockdown reduced them. Blocking ProTalpha translation abrogated the antiapoptotic effect of HuR, establishing that HuR's antiapoptotic function is vitally dependent on ProTalpha.","method":"RNA immunoprecipitation, polysome profiling, HuR overexpression and RNAi knockdown, chimeric mRNA reporter assay, apoptosis assay with translation-blocking oligomers","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2; multiple orthogonal methods establishing HuR-PTMA mRNA interaction and functional consequence; epistasis confirmed by rescue/block experiments","pmids":["15861128"],"is_preprint":false},{"year":2018,"finding":"PTMA (prothymosin-α) and histone H1 form an ultrahigh-affinity protein complex (picomolar Kd) in which both proteins fully retain their intrinsically disordered character. The interaction is driven by large opposite net charge of the two proteins, without requiring defined binding sites or interactions between specific individual residues. Single-molecule FRET, NMR, and molecular simulations confirmed the dynamic, fuzzy nature of the complex.","method":"Single-molecule FRET, NMR spectroscopy, molecular dynamics simulations, isothermal titration calorimetry","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1; multiple structural/biophysical methods (smFRET, NMR, MD simulations, ITC) in a single rigorous study","pmids":["29466338"],"is_preprint":false},{"year":2017,"finding":"PTMA participates in TGFβ1-induced fibrosis in primary human oral submucous fibroblasts. PTMA knockdown reversed TGFβ1-induced fibrosis by inhibiting fibroblast proliferation and reducing Collagen I, α-SMA, and MMP9 protein levels while increasing SMAD4 levels; conversely, PTMA overexpression enhanced the fibrotic process. PTMA expression was positively correlated with TGFβ1 and its downstream effector SMAD4.","method":"siRNA knockdown, overexpression, CCK-8 proliferation assay, Western blot for ECM markers, TGFβ1-induced fibrosis model, ELISA validation","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3; KD and OE with defined phenotypic readout, but pathway placement is correlative (bioinformatics) rather than fully reconstituted","pmids":["29088825"],"is_preprint":false},{"year":2021,"finding":"Macrophage-derived PTMA acts as a host-encoded trigger of Candida albicans yeast-to-filament transition. Bioactivity-guided fractionation of macrophage lysates coupled to mass spectrometry identified PTMA as a filament-inducing component, and immunoneutralization of PTMA within lysate abolished filamentation activity. Enzymatic treatment implicated a phosphorylated protein as the active species.","method":"Bioactivity-guided biochemical fractionation, mass spectrometry identification, immunoneutralization, C. albicans filamentation assay","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2; fractionation plus immunoneutralization provide strong functional evidence but no atomic-resolution mechanism","pmids":["34433036"],"is_preprint":false},{"year":2023,"finding":"PTMA binds to HMGB1 and this interaction regulates mitochondrial oxidative phosphorylation in esophageal squamous cell carcinoma cells. PTMA knockdown induced ROS accumulation and inhibited mitochondrial oxidative phosphorylation; HMGB1 overexpression in PTMA-knockdown cells reversed these effects, positioning PTMA upstream of HMGB1 in mitochondrial metabolic regulation.","method":"Co-immunoprecipitation, immunofluorescence co-localization, siRNA knockdown, HMGB1 overexpression rescue, DCFH-DA ROS assay, MitoSOX, JC-1 staining, mitochondrial complex activity assay","journal":"Journal of thoracic disease","confidence":"Medium","confidence_rationale":"Tier 2-3; Co-IP plus functional rescue establishes interaction and pathway placement, but single lab, single study","pmids":["37065565"],"is_preprint":false},{"year":2025,"finding":"PTMA is a critical regulator of cardiomyocyte proliferation and cardiac regeneration. Mechanistically, PTMA interacts with MBD3 and inhibits its deacetylation activity within the MBD3/HDAC1 NuRD complex, leading to increased STAT3 acetylation, which in turn promotes STAT3 phosphorylation and transcriptional activation of proliferative target genes. Conditional cardiomyocyte-specific Ptma knockout impaired neonatal heart regeneration; AAV9-mediated overexpression extended the neonatal proliferative window and showed therapeutic promise in adult heart injury models.","method":"Single-cell RNA sequencing, primary cardiomyocyte overexpression/KO, human iPSC-derived cardiomyocytes, conditional knockout mouse model, AAV9 in vivo delivery, Co-immunoprecipitation (PTMA-MBD3 interaction), STAT3 acetylation/phosphorylation Western blot, deacetylase activity assay","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1-2; multiple orthogonal methods including genetic KO, overexpression in multiple species, Co-IP, enzymatic activity assay, and in vivo AAV rescue in a single rigorous study","pmids":["40408476"],"is_preprint":false},{"year":2025,"finding":"PTMA functions as a linker histone chaperone essential for efficient DNA damage repair by promoting H1.0 release from chromatin at damage sites. In PTMA-null (Ptma-/-) cells, DNA damage-induced exit of H1.0 from irradiated chromatin regions was impaired, and recruitment of PARP1 to damaged DNA was inhibited. PTMA thus facilitates local chromatin de-condensation necessary for repair protein access; Ptma-/- cells showed increased sensitivity to DNA-damaging agents.","method":"Photoconvertible fluorescent protein-tagged H1.0 live imaging, microirradiation-induced DNA lesions, PARP1 recruitment imaging, Ptma-/- homozygous null cell lines (CRISPR), H1.0 tight-binding mutant overexpression, clonogenic survival assay","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 1-2; live-cell imaging with functional genetic knockout, multiple mutant controls, and direct phenotypic readouts (PARP1 recruitment, DNA damage sensitivity) in single rigorous study","pmids":["40474236"],"is_preprint":false},{"year":2026,"finding":"PTMA is directly transcriptionally controlled by TCF1 in progenitor exhausted CD8 T cells (TPEX) and preserves mitochondrial DNA integrity through physical interaction with TFAM (mitochondrial transcription factor A), sustaining oxidative phosphorylation under metabolic stress. Genetic deletion of Ptma from T cells compromised CD8 T cell persistence in tumors and abolished therapeutic efficacy of PD-1 blockade in mice.","method":"Transcriptome analysis of patient CD8 T cells, genetic T cell-specific Ptma deletion in mice, PD-1 blockade tumor models, Co-immunoprecipitation (PTMA-TFAM), mitochondrial function assays, TCF1 ChIP/reporter analysis","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1-2; genetic KO with in vivo tumor immunotherapy phenotype, Co-IP interaction with TFAM, and mitochondrial functional assays in single rigorous study","pmids":["41544148"],"is_preprint":false}],"current_model":"PTMA (prothymosin alpha) is a multifunctional intrinsically disordered nuclear protein that: (1) inhibits apoptosome formation by blocking caspase-9 activation; (2) competes with Nrf2 for Keap1 binding to derepress oxidative stress-protective gene transcription; (3) interacts with histone H1 via electrostatic charge complementarity to act as a linker histone chaperone, facilitating H1 eviction and PARP1 recruitment at DNA damage sites; (4) inhibits the MBD3/HDAC1 NuRD deacetylase complex to promote STAT3 acetylation and cardiomyocyte proliferation; (5) interacts with TFAM to maintain mitochondrial DNA integrity and oxidative phosphorylation in CD8 T cells; and (6) acts as a post-transcriptional target of HuR, whose binding promotes PTMA translation and antiapoptotic signaling."},"narrative":{"teleology":[{"year":1986,"claim":"Cloning of PTMA established it as a highly acidic, signal-peptide-lacking nuclear protein whose mRNA is sharply induced by mitogens and serum, linking it to proliferating cells.","evidence":"cDNA cloning, Northern blot in mitogen-stimulated lymphocytes and serum-restimulated NIH 3T3 cells","pmids":["3467312"],"confidence":"High","gaps":["No functional role defined beyond expression correlation with proliferation","No binding partners identified"]},{"year":2003,"claim":"Biochemical fractionation and RNAi demonstrated that PTMA acts as an endogenous inhibitor of apoptosome formation, directly opposing caspase-9 activation and defining its first molecular mechanism.","evidence":"Biochemical fractionation, PETCM chemical genetics, RNAi knockdown, UV-induced apoptosis assay in human cell lines","pmids":["12522243"],"confidence":"High","gaps":["Structural basis of apoptosome inhibition not resolved","Relative contribution versus other antiapoptotic factors in vivo unknown"]},{"year":2005,"claim":"Two independent studies expanded PTMA's functions beyond apoptosis: one showed PTMA competes with Nrf2 for Keap1 binding to activate antioxidant transcription, while another demonstrated that HuR binding to PTMA mRNA drives its translation to execute HuR's antiapoptotic program.","evidence":"Yeast two-hybrid, in vitro competition pulldown, Nrf2 reporter assays (Keap1); RNA immunoprecipitation, polysome profiling, translation-blocking oligomers (HuR–PTMA mRNA)","pmids":["15657435","15861128"],"confidence":"High","gaps":["Whether Keap1 competition and apoptosome inhibition are coordinated or independent arms of PTMA signaling","Post-translational modifications regulating PTMA–Keap1 interaction unknown"]},{"year":2018,"claim":"Biophysical dissection revealed that PTMA and histone H1 form a picomolar-affinity complex in which both proteins remain fully disordered, establishing a charge-driven 'fuzzy' interaction paradigm for intrinsically disordered proteins.","evidence":"Single-molecule FRET, NMR, molecular dynamics simulations, isothermal titration calorimetry with purified recombinant proteins","pmids":["29466338"],"confidence":"High","gaps":["Functional consequence of H1 binding for chromatin biology not yet demonstrated at the time","In vivo relevance of the picomolar affinity not tested"]},{"year":2023,"claim":"Co-immunoprecipitation and rescue experiments positioned PTMA upstream of HMGB1 in maintaining mitochondrial oxidative phosphorylation and suppressing ROS in esophageal squamous cell carcinoma cells.","evidence":"Co-IP, siRNA knockdown with HMGB1 overexpression rescue, ROS and mitochondrial complex activity assays in ESCC cells","pmids":["37065565"],"confidence":"Medium","gaps":["Single-lab observation; independent confirmation needed","Direct versus indirect nature of PTMA–HMGB1 interaction not resolved","Generalizability beyond ESCC unclear"]},{"year":2025,"claim":"Two studies converged to establish PTMA as a linker histone chaperone critical for DNA damage repair and as an inhibitor of the MBD3/HDAC1 NuRD complex that drives STAT3-dependent cardiomyocyte proliferation, respectively extending the H1-binding and chromatin-regulatory functions to defined physiological contexts.","evidence":"CRISPR Ptma-/- cells with microirradiation live imaging and PARP1 recruitment (DNA repair); conditional cardiomyocyte Ptma KO mice, Co-IP with MBD3, HDAC activity assays, AAV9 rescue (cardiac regeneration)","pmids":["40474236","40408476"],"confidence":"High","gaps":["Whether H1 chaperone and NuRD inhibition functions are structurally separable within PTMA","Upstream signals controlling PTMA's choice among distinct interactors remain uncharacterized"]},{"year":2026,"claim":"Genetic deletion of Ptma from T cells revealed that PTMA sustains mitochondrial DNA integrity via TFAM interaction and is required for CD8 T cell persistence in tumors and for anti-PD-1 therapeutic efficacy, establishing a non-redundant immunometabolic role.","evidence":"T cell-specific Ptma KO mice, PD-1 blockade tumor models, Co-IP of PTMA–TFAM, mitochondrial function assays, TCF1 ChIP","pmids":["41544148"],"confidence":"High","gaps":["Whether PTMA–TFAM interaction occurs in non-immune cells","Structural basis of PTMA–TFAM complex unknown","Contribution of other PTMA functions (apoptosis inhibition, chromatin remodeling) to the T cell phenotype not dissected"]},{"year":null,"claim":"How PTMA's multiple interaction surfaces—apoptosome inhibition, Keap1 competition, H1 chaperoning, NuRD complex inhibition, and TFAM binding—are coordinately regulated in a single cell remains an open question; no structural or post-translational modification framework integrates these activities.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of any PTMA complex beyond biophysical characterization of the fuzzy H1 interaction","Post-translational modifications (e.g., phosphorylation) that partition PTMA among its partners not systematically mapped","In vivo genetic dissection separating individual PTMA functions not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[4,9]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,8]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[4,9]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,4,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,2]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,3]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[2,7]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[9]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,8]}],"complexes":["MBD3/HDAC1 NuRD complex (inhibitory interaction)"],"partners":["H1F0","KEAP1","MBD3","TFAM","HMGB1","ELAVL1","PARP1"],"other_free_text":[]},"mechanistic_narrative":"Prothymosin alpha (PTMA) is a highly acidic, intrinsically disordered nuclear protein that couples chromatin remodeling, apoptosis regulation, and metabolic maintenance to cell proliferation and stress responses. PTMA inhibits apoptosome-mediated caspase-9 activation [PMID:12522243], competes with Nrf2 for Keap1 binding to derepress antioxidant gene transcription [PMID:15657435], and forms an ultrahigh-affinity disordered complex with linker histone H1 that enables H1 eviction and PARP1 recruitment at DNA damage sites [PMID:29466338, PMID:40474236]. PTMA also inhibits the MBD3/HDAC1 NuRD deacetylase complex to promote STAT3 acetylation-dependent cardiomyocyte proliferation [PMID:40408476] and interacts with TFAM to maintain mitochondrial DNA integrity and oxidative phosphorylation in CD8 T cells, where its loss abolishes anti-PD-1 therapeutic efficacy [PMID:41544148]."},"prefetch_data":{"uniprot":{"accession":"P06454","full_name":"Prothymosin alpha","aliases":[],"length_aa":111,"mass_kda":12.2,"function":"Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P06454/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/PTMA","classification":"Common Essential","n_dependent_lines":735,"n_total_lines":1208,"dependency_fraction":0.6084437086092715},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000187514","cell_line_id":"CID001263","localizations":[{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"RPS27A","stoichiometry":10.0},{"gene":"SRP9;DKFZP564M2223","stoichiometry":4.0},{"gene":"INPPL1","stoichiometry":0.2},{"gene":"KEAP1","stoichiometry":0.2},{"gene":"MKI67","stoichiometry":0.2},{"gene":"KPNA1","stoichiometry":0.2},{"gene":"ELMSAN1","stoichiometry":0.2},{"gene":"MRPL3","stoichiometry":0.2},{"gene":"SRP14","stoichiometry":0.2},{"gene":"CCDC137","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001263","total_profiled":1310},"omim":[{"mim_id":"614663","title":"RALY HETEROGENEOUS NUCLEAR RIBONUCLEAR PROTEIN; RALY","url":"https://www.omim.org/entry/614663"},{"mim_id":"612428","title":"RNA-BINDING MOTIF PROTEIN 38; RBM38","url":"https://www.omim.org/entry/612428"},{"mim_id":"600832","title":"ACIDIC NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A","url":"https://www.omim.org/entry/600832"},{"mim_id":"188390","title":"PROTHYMOSIN, ALPHA; PTMA","url":"https://www.omim.org/entry/188390"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PTMA"},"hgnc":{"alias_symbol":[],"prev_symbol":["TMSA"]},"alphafold":{"accession":"P06454","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P06454","model_url":"https://alphafold.ebi.ac.uk/files/AF-P06454-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P06454-F1-predicted_aligned_error_v6.png","plddt_mean":58.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PTMA","jax_strain_url":"https://www.jax.org/strain/search?query=PTMA"},"sequence":{"accession":"P06454","fasta_url":"https://rest.uniprot.org/uniprotkb/P06454.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P06454/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P06454"}},"corpus_meta":[{"pmid":"31960446","id":"PMC_31960446","title":"Circular RNA hsa_circ_0004277 contributes to malignant phenotype of colorectal cancer by sponging miR-512-5p to upregulate the expression of PTMA.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31960446","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30988666","id":"PMC_30988666","title":"Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB).","date":"2019","source":"Clinical proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/30988666","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36968197","id":"PMC_36968197","title":"The simultaneous administration of microplastics and cadmium alters rat testicular activity and changes the expression of PTMA, DAAM1 and PREP.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36968197","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34433036","id":"PMC_34433036","title":"The macrophage-derived protein PTMA induces filamentation of the human fungal pathogen Candida albicans.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34433036","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37414786","id":"PMC_37414786","title":"Multimodal investigation of electronic transport in PTMA and its impact on organic radical battery performance.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37414786","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29088825","id":"PMC_29088825","title":"PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29088825","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37065565","id":"PMC_37065565","title":"PTMA binds to HMGB1 to regulate mitochondrial oxidative phosphorylation and thus affect the malignant progression of esophageal squamous cell carcinoma.","date":"2023","source":"Journal of thoracic disease","url":"https://pubmed.ncbi.nlm.nih.gov/37065565","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40408476","id":"PMC_40408476","title":"PTMA controls cardiomyocyte proliferation and cardiac repair by enhancing STAT3 acetylation.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40408476","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37852614","id":"PMC_37852614","title":"Practical Cell Design for PTMA-Based Organic Batteries: an Experimental and Modeling Study.","date":"2023","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/37852614","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41544148","id":"PMC_41544148","title":"PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells.","date":"2026","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41544148","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40474236","id":"PMC_40474236","title":"The linker histone chaperone Prothymosin α (PTMA) is essential for efficient DNA damage repair and the recruitment of PARP1.","date":"2025","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/40474236","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40629240","id":"PMC_40629240","title":"The Complicity of DAAM1, PTMA, RSPH6A, and Steroidogenic Genes in the Fertility of Male Rats Exposed to Cadmium During Gestation and Lactation: Attenuation by PREOG.","date":"2025","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/40629240","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18391951","id":"PMC_18391951","title":"Many sequence variants affecting diversity of adult human height.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18391951","citation_count":520,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29466338","id":"PMC_29466338","title":"Extreme disorder in an ultrahigh-affinity protein complex.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29466338","citation_count":515,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15257295","id":"PMC_15257295","title":"Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15257295","citation_count":412,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12522243","id":"PMC_12522243","title":"Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12522243","citation_count":329,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26618866","id":"PMC_26618866","title":"∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26618866","citation_count":209,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32203420","id":"PMC_32203420","title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203420","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3467312","id":"PMC_3467312","title":"The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA.","date":"1986","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3467312","citation_count":193,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15657435","id":"PMC_15657435","title":"Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15657435","citation_count":160,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15861128","id":"PMC_15861128","title":"Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15861128","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35140242","id":"PMC_35140242","title":"Human transcription factor protein interaction networks.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35140242","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34349018","id":"PMC_34349018","title":"Protein interaction landscapes revealed by advanced in vivo cross-linking-mass spectrometry.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34349018","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31753913","id":"PMC_31753913","title":"Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31753913","citation_count":110,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7535,"output_tokens":1891,"usd":0.025485},"stage2":{"model":"claude-opus-4-6","input_tokens":5143,"output_tokens":2400,"usd":0.128573},"total_usd":0.35754,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":18700,"output_tokens":4571,"usd":0.062332},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6920,"output_tokens":2380,"usd":0.14115}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2025,\n      \"finding\": \"PTMA acts as a linker histone chaperone that promotes release of histone H1.0 from chromatin at DNA damage sites, enabling local chromatin de-condensation and efficient recruitment of the DNA repair protein PARP1. In Ptma-/- cells, H1.0 exit from irradiated chromatin is impaired, PARP1 recruitment is inhibited, and cells show increased sensitivity to DNA-damaging agents.\",\n      \"method\": \"Live-cell imaging with photoconvertible fluorescent protein-tagged H1.0, Ptma-/- and Parp1-/- knockout cell lines, microirradiation-induced DNA damage, overexpression of tight-binding H1.0 mutant\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, multiple orthogonal methods (live imaging, genetic knockouts, DNA damage sensitivity), single lab but rigorous controls\",\n      \"pmids\": [\"40474236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PTMA interacts with MBD3 and inhibits the deacetylation activity of the MBD3/HDAC1 NuRD complex, leading to increased STAT3 acetylation. This increased STAT3 acetylation positively regulates STAT3 phosphorylation and activation of its target genes, promoting cardiomyocyte proliferation and cardiac regeneration.\",\n      \"method\": \"Co-immunoprecipitation, conditional cardiomyocyte-specific Ptma knockout, AAV9-mediated PTMA overexpression, STAT3 acetylation/phosphorylation western blotting, primary cardiomyocyte and human iPSC-derived cardiomyocyte proliferation assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, clean conditional KO and OE with defined cellular and in vivo phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"40408476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PTMA preserves mitochondrial DNA integrity through direct interaction with mitochondrial transcription factor A (TFAM), sustaining CD8 T cell oxidative phosphorylation under metabolic stress. PTMA expression in progenitor exhausted T cells is directly controlled by TCF1. Genetic deletion of Ptma from T cells compromised CD8 T cell persistence in tumors and abolished the therapeutic effect of PD-1 blockade.\",\n      \"method\": \"Genetic deletion of Ptma in T cells, interaction assay with TFAM, transcriptomic analysis of CD8 T cells from ICB-treated patients, mitochondrial function assays, in vivo tumor models with PD-1 blockade\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined in vivo phenotype, protein-protein interaction, mechanistic pathway placement via TCF1-PTMA-TFAM axis\",\n      \"pmids\": [\"41544148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PTMA binds to HMGB1 (High Mobility Group Box 1) protein, and this interaction regulates mitochondrial oxidative phosphorylation in esophageal squamous cell carcinoma cells. Knockdown of PTMA induces ROS accumulation by inhibiting mitochondrial oxidative phosphorylation, an effect mediated through the PTMA-HMGB1 interaction.\",\n      \"method\": \"Co-immunoprecipitation (co-IP), immunofluorescence co-localization, siRNA knockdown, DCFH-DA ROS assay, JC-1 mitochondrial membrane potential staining, mitochondrial complex activity assay, HMGB1 overexpression rescue experiment\",\n      \"journal\": \"Journal of thoracic disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with functional rescue experiment, single lab, multiple methods but limited mechanistic depth\",\n      \"pmids\": [\"37065565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PTMA participates in TGFβ1-induced fibrosis in primary human oral submucous fibroblasts. PTMA knockdown reversed TGFβ1-induced fibrosis by inhibiting fibroblast proliferation and reducing Collagen I, α-SMA, and MMP9 protein levels while increasing SMAD4. PTMA overexpression enhanced TGFβ1-induced fibrosis. Bioinformatics and correlation analysis indicated PTMA is positively correlated with TGFβ1 and its downstream gene SMAD4.\",\n      \"method\": \"siRNA knockdown, PTMA overexpression, TGFβ1-induced fibrosis cell model, western blot for ECM markers, cell viability/proliferation assays, Spearman correlation analysis of public databases\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KD/OE with defined cellular phenotype and pathway markers, single lab, no direct binding assay for TGFβ1/SMAD pathway\",\n      \"pmids\": [\"29088825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PTMA expression is upregulated by the circRNA hsa_circ_0004277 acting as a sponge for miR-512-5p, which normally suppresses PTMA. This circ-0004277/miR-512-5p/PTMA axis promotes colorectal cancer cell proliferation and inhibits apoptosis.\",\n      \"method\": \"qRT-PCR, miRNA sponge/luciferase reporter assays, siRNA knockdown, rescue assay with miR-512-5p mimic and PTMA overexpression, flow cytometry for apoptosis\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — ceRNA regulatory mechanism with rescue assay, single lab, indirect regulation of PTMA rather than direct mechanistic characterization of PTMA itself\",\n      \"pmids\": [\"31960446\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PTMA (Prothymosin alpha) is a multifunctional nuclear/chromatin-associated protein that acts as a linker histone (H1) chaperone to promote chromatin decompaction and PARP1 recruitment at DNA damage sites; interacts with MBD3 to inhibit the NuRD/HDAC1 deacetylase complex, thereby increasing STAT3 acetylation and phosphorylation to drive cardiomyocyte proliferation; preserves mitochondrial DNA integrity by interacting with TFAM to sustain oxidative phosphorylation in CD8 T cells (regulated upstream by TCF1); and binds HMGB1 to regulate mitochondrial oxidative phosphorylation in cancer cells, with additional roles in TGFβ1/SMAD-mediated fibrosis and tumor cell proliferation downstream of ceRNA-mediated post-transcriptional regulation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper before extracting discoveries.\n\n**RETRIEVED PAPERS (12):**\n1. hsa_circ_0004277 → EXCLUDE (circRNA/alt-locus product, case B)\n2. PTMA as ESCC biomarker → EXCLUDE (expression/biomarker, no mechanism)\n3. MP+Cd effects on PTMA in rat testis → KEEP (describes PTMA protein role in germ cell proliferation/differentiation)\n4. PTMA induces C. albicans filamentation → KEEP (describes mammalian PTMA protein function)\n5. PTMA polymer organic battery → EXCLUDE (symbol collision — poly(TEMPO methacrylate), not the gene)\n6. PTMA in oral submucous fibrosis → KEEP (KD/OE with TGFβ1/SMAD4 pathway)\n7. PTMA binds HMGB1, mitochondrial oxidative phosphorylation → KEEP (Co-IP, functional mechanism)\n8. PTMA controls cardiomyocyte proliferation via STAT3 acetylation → KEEP (mechanistic, MBD3/HDAC1/NuRD)\n9. PTMA-based organic batteries → EXCLUDE (symbol collision — polymer)\n10. PTMA safeguards mitochondrial integrity in CD8 T cells → KEEP (TFAM interaction, TCF1 axis)\n11. PTMA as linker histone chaperone, DNA damage repair → KEEP (PARP1 recruitment, H1.0 interaction)\n12. DAAM1, PTMA, RSPH6A in male fertility → KEEP (expression in spermatogenesis context, limited mechanism)\n\n**GENE2PUBMED PAPERS (30):**\n- PMID:17081983 (phosphoproteomics) → EXCLUDE (large-scale, not PTMA-specific)\n- PMID:12477932 (MGC cDNA) → EXCLUDE (genomics resource)\n- PMID:26496610 (HeLa interactome) → EXCLUDE (not PTMA-specific)\n- PMID:25416956 (human interactome) → EXCLUDE (not PTMA-specific)\n- PMID:32296183 (HuRI) → EXCLUDE (not PTMA-specific)\n- PMID:22939629 (protein complexes census) → EXCLUDE (not PTMA-specific)\n- PMID:21873635 (GO phylogenetic) → EXCLUDE\n- PMID:18391951 (GWAS height) → EXCLUDE\n- PMID:29466338 (H1 + prothymosin-α disordered complex) → KEEP (direct structural/biophysical study of PTMA)\n- PMID:8125298 (oligo-capping method) → EXCLUDE\n- PMID:15489334 (MGC) → EXCLUDE\n- PMID:26638075 (centrosome BioID) → EXCLUDE\n- PMID:35271311 (OpenCell) → EXCLUDE\n- PMID:15257295 (HuR and AUF1 binding) → EXCLUDE (about HuR/AUF1, PTMA mRNA mentioned only peripherally)\n- PMID:26344197 (metazoan complexes) → EXCLUDE\n- PMID:26618866 (CFTR interactome) → EXCLUDE\n- PMID:32203420 (RhoGEF/RhoGAP) → EXCLUDE\n- PMID:3467312 (human PTMA gene cloned, growth-induced) → KEEP (foundational cloning + expression)\n- PMID:23602568 (CMGC kinase interactions) → EXCLUDE\n- PMID:15657435 (PTMA-Keap1-Nrf2) → KEEP (direct mechanism)\n- PMID:15861128 (HuR antiapoptotic via ProTalpha) → KEEP (direct mechanism)\n- PMID:19322201 (HuR ubiquitination) → EXCLUDE (about HuR, PTMA mentioned only as target mRNA)\n- PMID:29117863 (TRIM25) → EXCLUDE\n- PMID:23376485 (podocyte exosomes) → EXCLUDE\n- PMID:35140242 (TF interactions) → EXCLUDE\n- PMID:18029348 (subcellular atlas) → EXCLUDE\n- PMID:34349018 (XL-MS) → EXCLUDE\n- PMID:31753913 (bromodomain) → EXCLUDE\n- PMID:12522243 (PHAP/ProT apoptosis pathway) → KEEP (direct mechanism)\n- PMID:22863883 (interactome temporal) → EXCLUDE\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1986,\n      \"finding\": \"Human prothymosin alpha (PTMA) was cloned from cDNA libraries and shown to encode a highly acidic 111-amino-acid protein with no N-terminal signal peptide. PTMA mRNA is induced >15-fold upon mitogen stimulation of resting lymphocytes and similarly elevated by serum restitution in serum-deprived NIH 3T3 cells, establishing a direct link between PTMA expression and cell proliferation.\",\n      \"method\": \"cDNA cloning, sequencing, Northern blot, mitogen stimulation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 foundational cloning with multiple orthogonal methods; replicated in multiple cell types in same study\",\n      \"pmids\": [\"3467312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Prothymosin alpha (ProT) negatively regulates caspase-9 activation by inhibiting apoptosome formation at physiological dATP concentrations. This was identified via biochemical fractionation and a small-molecule activator (PETCM) approach; RNAi-mediated elimination of ProT sensitized cells to UV-induced apoptosis and eliminated the requirement for PETCM in caspase activation. PHAP proteins (tumor suppressors) and ProT (oncoprotein) thus constitute opposing regulators of mitochondria-initiated caspase activation.\",\n      \"method\": \"Biochemical fractionation, high-throughput screening with PETCM, caspase activation assays, RNAi knockdown, UV-induced apoptosis assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2; multiple orthogonal methods (fractionation, chemical genetics, RNAi, functional apoptosis assays) in a single rigorous study; highly cited foundational paper\",\n      \"pmids\": [\"12522243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PTMA (prothymosin alpha) directly interacts with Keap1, the cytoplasmic inhibitor of transcription factor Nrf2. PTMA competes with Nrf2 for binding to the same domain of Keap1 in vitro, thereby liberating Nrf2 from its inhibitory complex. In vivo, PTMA levels positively correlate with Nrf2-dependent transcription of oxidative stress-protecting genes. Keap1 was shown to be a nuclear-cytoplasmic shuttling protein with a nuclear export signal critical for its inhibitory action.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro pulldown/competition assay, in vivo co-immunoprecipitation, overexpression and mRNA interference, reporter assays for Nrf2-dependent transcription\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2; yeast two-hybrid discovery confirmed by in vitro direct interaction assay and in vivo functional correlation with multiple methods\",\n      \"pmids\": [\"15657435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RNA-binding protein HuR binds the PTMA (ProTalpha) mRNA and promotes its cytoplasmic translocation and translation, thereby exerting an antiapoptotic effect. Upon UV treatment, ProTalpha mRNA association with HuR on heavy polysomes increased dramatically. HuR overexpression increased ProTalpha translation and protein levels, while HuR knockdown reduced them. Blocking ProTalpha translation abrogated the antiapoptotic effect of HuR, establishing that HuR's antiapoptotic function is vitally dependent on ProTalpha.\",\n      \"method\": \"RNA immunoprecipitation, polysome profiling, HuR overexpression and RNAi knockdown, chimeric mRNA reporter assay, apoptosis assay with translation-blocking oligomers\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2; multiple orthogonal methods establishing HuR-PTMA mRNA interaction and functional consequence; epistasis confirmed by rescue/block experiments\",\n      \"pmids\": [\"15861128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PTMA (prothymosin-α) and histone H1 form an ultrahigh-affinity protein complex (picomolar Kd) in which both proteins fully retain their intrinsically disordered character. The interaction is driven by large opposite net charge of the two proteins, without requiring defined binding sites or interactions between specific individual residues. Single-molecule FRET, NMR, and molecular simulations confirmed the dynamic, fuzzy nature of the complex.\",\n      \"method\": \"Single-molecule FRET, NMR spectroscopy, molecular dynamics simulations, isothermal titration calorimetry\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1; multiple structural/biophysical methods (smFRET, NMR, MD simulations, ITC) in a single rigorous study\",\n      \"pmids\": [\"29466338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PTMA participates in TGFβ1-induced fibrosis in primary human oral submucous fibroblasts. PTMA knockdown reversed TGFβ1-induced fibrosis by inhibiting fibroblast proliferation and reducing Collagen I, α-SMA, and MMP9 protein levels while increasing SMAD4 levels; conversely, PTMA overexpression enhanced the fibrotic process. PTMA expression was positively correlated with TGFβ1 and its downstream effector SMAD4.\",\n      \"method\": \"siRNA knockdown, overexpression, CCK-8 proliferation assay, Western blot for ECM markers, TGFβ1-induced fibrosis model, ELISA validation\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3; KD and OE with defined phenotypic readout, but pathway placement is correlative (bioinformatics) rather than fully reconstituted\",\n      \"pmids\": [\"29088825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Macrophage-derived PTMA acts as a host-encoded trigger of Candida albicans yeast-to-filament transition. Bioactivity-guided fractionation of macrophage lysates coupled to mass spectrometry identified PTMA as a filament-inducing component, and immunoneutralization of PTMA within lysate abolished filamentation activity. Enzymatic treatment implicated a phosphorylated protein as the active species.\",\n      \"method\": \"Bioactivity-guided biochemical fractionation, mass spectrometry identification, immunoneutralization, C. albicans filamentation assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2; fractionation plus immunoneutralization provide strong functional evidence but no atomic-resolution mechanism\",\n      \"pmids\": [\"34433036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PTMA binds to HMGB1 and this interaction regulates mitochondrial oxidative phosphorylation in esophageal squamous cell carcinoma cells. PTMA knockdown induced ROS accumulation and inhibited mitochondrial oxidative phosphorylation; HMGB1 overexpression in PTMA-knockdown cells reversed these effects, positioning PTMA upstream of HMGB1 in mitochondrial metabolic regulation.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence co-localization, siRNA knockdown, HMGB1 overexpression rescue, DCFH-DA ROS assay, MitoSOX, JC-1 staining, mitochondrial complex activity assay\",\n      \"journal\": \"Journal of thoracic disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3; Co-IP plus functional rescue establishes interaction and pathway placement, but single lab, single study\",\n      \"pmids\": [\"37065565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PTMA is a critical regulator of cardiomyocyte proliferation and cardiac regeneration. Mechanistically, PTMA interacts with MBD3 and inhibits its deacetylation activity within the MBD3/HDAC1 NuRD complex, leading to increased STAT3 acetylation, which in turn promotes STAT3 phosphorylation and transcriptional activation of proliferative target genes. Conditional cardiomyocyte-specific Ptma knockout impaired neonatal heart regeneration; AAV9-mediated overexpression extended the neonatal proliferative window and showed therapeutic promise in adult heart injury models.\",\n      \"method\": \"Single-cell RNA sequencing, primary cardiomyocyte overexpression/KO, human iPSC-derived cardiomyocytes, conditional knockout mouse model, AAV9 in vivo delivery, Co-immunoprecipitation (PTMA-MBD3 interaction), STAT3 acetylation/phosphorylation Western blot, deacetylase activity assay\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2; multiple orthogonal methods including genetic KO, overexpression in multiple species, Co-IP, enzymatic activity assay, and in vivo AAV rescue in a single rigorous study\",\n      \"pmids\": [\"40408476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PTMA functions as a linker histone chaperone essential for efficient DNA damage repair by promoting H1.0 release from chromatin at damage sites. In PTMA-null (Ptma-/-) cells, DNA damage-induced exit of H1.0 from irradiated chromatin regions was impaired, and recruitment of PARP1 to damaged DNA was inhibited. PTMA thus facilitates local chromatin de-condensation necessary for repair protein access; Ptma-/- cells showed increased sensitivity to DNA-damaging agents.\",\n      \"method\": \"Photoconvertible fluorescent protein-tagged H1.0 live imaging, microirradiation-induced DNA lesions, PARP1 recruitment imaging, Ptma-/- homozygous null cell lines (CRISPR), H1.0 tight-binding mutant overexpression, clonogenic survival assay\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2; live-cell imaging with functional genetic knockout, multiple mutant controls, and direct phenotypic readouts (PARP1 recruitment, DNA damage sensitivity) in single rigorous study\",\n      \"pmids\": [\"40474236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PTMA is directly transcriptionally controlled by TCF1 in progenitor exhausted CD8 T cells (TPEX) and preserves mitochondrial DNA integrity through physical interaction with TFAM (mitochondrial transcription factor A), sustaining oxidative phosphorylation under metabolic stress. Genetic deletion of Ptma from T cells compromised CD8 T cell persistence in tumors and abolished therapeutic efficacy of PD-1 blockade in mice.\",\n      \"method\": \"Transcriptome analysis of patient CD8 T cells, genetic T cell-specific Ptma deletion in mice, PD-1 blockade tumor models, Co-immunoprecipitation (PTMA-TFAM), mitochondrial function assays, TCF1 ChIP/reporter analysis\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2; genetic KO with in vivo tumor immunotherapy phenotype, Co-IP interaction with TFAM, and mitochondrial functional assays in single rigorous study\",\n      \"pmids\": [\"41544148\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PTMA (prothymosin alpha) is a multifunctional intrinsically disordered nuclear protein that: (1) inhibits apoptosome formation by blocking caspase-9 activation; (2) competes with Nrf2 for Keap1 binding to derepress oxidative stress-protective gene transcription; (3) interacts with histone H1 via electrostatic charge complementarity to act as a linker histone chaperone, facilitating H1 eviction and PARP1 recruitment at DNA damage sites; (4) inhibits the MBD3/HDAC1 NuRD deacetylase complex to promote STAT3 acetylation and cardiomyocyte proliferation; (5) interacts with TFAM to maintain mitochondrial DNA integrity and oxidative phosphorylation in CD8 T cells; and (6) acts as a post-transcriptional target of HuR, whose binding promotes PTMA translation and antiapoptotic signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PTMA (Prothymosin alpha) is a multifunctional chromatin- and mitochondria-associated protein that maintains genome integrity and metabolic fitness through distinct protein–protein interactions. It functions as a linker histone H1 chaperone, promoting H1.0 release from damaged chromatin to enable local decompaction and efficient PARP1 recruitment during the DNA damage response; loss of PTMA impairs H1.0 dynamics and sensitizes cells to genotoxic stress [PMID:40474236]. PTMA also interacts with MBD3 to inhibit the NuRD/HDAC1 deacetylase complex, increasing STAT3 acetylation and phosphorylation to drive cardiomyocyte proliferation and cardiac regeneration [PMID:40408476]. In CD8 T cells, TCF1-driven PTMA preserves mitochondrial DNA integrity through direct interaction with TFAM, sustaining oxidative phosphorylation required for anti-tumor T cell persistence and responsiveness to PD-1 blockade [PMID:41544148]; a parallel role in mitochondrial oxidative phosphorylation operates through PTMA–HMGB1 binding in cancer cells [PMID:37065565].\",\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Whether PTMA participates in TGFβ1/SMAD-mediated fibrotic signaling was unknown; knockdown and overexpression experiments established that PTMA positively regulates TGFβ1-induced fibroblast proliferation and ECM deposition, linking it to fibrotic pathology.\",\n      \"evidence\": \"siRNA knockdown and overexpression in TGFβ1-treated primary human oral submucous fibroblasts with western blot for collagen I, α-SMA, and SMAD4\",\n      \"pmids\": [\"29088825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct binding assay between PTMA and TGFβ1/SMAD pathway components\",\n        \"Mechanism by which PTMA modulates SMAD4 levels is unresolved\",\n        \"Single cell type studied\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How PTMA expression is post-transcriptionally regulated in cancer was unclear; a ceRNA axis (hsa_circ_0004277/miR-512-5p/PTMA) was shown to upregulate PTMA and promote colorectal cancer cell proliferation.\",\n      \"evidence\": \"Luciferase reporter assays, miRNA mimic rescue, and siRNA knockdown in colorectal cancer cell lines\",\n      \"pmids\": [\"31960446\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"This describes upstream regulation of PTMA rather than a direct mechanistic activity of the protein\",\n        \"In vivo relevance of the ceRNA axis not tested\",\n        \"Downstream effectors of PTMA-driven proliferation in this context not identified\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Whether PTMA directly influences mitochondrial metabolism was unknown; PTMA was shown to bind HMGB1 and sustain mitochondrial oxidative phosphorylation, with PTMA depletion causing ROS accumulation in cancer cells.\",\n      \"evidence\": \"Co-IP, immunofluorescence co-localization, siRNA knockdown with HMGB1 rescue, mitochondrial complex activity and ROS assays in esophageal squamous cell carcinoma cells\",\n      \"pmids\": [\"37065565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"PTMA–HMGB1 interaction confirmed by co-IP but structural basis and direct vs. indirect mitochondrial mechanism unknown\",\n        \"Whether PTMA localizes to mitochondria or acts indirectly through HMGB1 nuclear functions is unresolved\",\n        \"Single cancer cell line studied\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The mechanism by which chromatin decompacts at DNA damage sites remained incompletely understood; PTMA was identified as a linker histone H1.0 chaperone that drives H1.0 eviction from damaged chromatin, enabling PARP1 recruitment and DNA repair.\",\n      \"evidence\": \"Live-cell imaging of photoconvertible H1.0, Ptma−/− and Parp1−/− knockout cell lines, microirradiation, DNA damage sensitivity assays\",\n      \"pmids\": [\"40474236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether PTMA acts on other H1 variants beyond H1.0 is untested\",\n        \"Structural basis of the PTMA–H1 chaperone interaction not resolved\",\n        \"Contribution to specific DNA repair pathways (HR vs. NHEJ) not delineated\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"How PTMA influences epigenetic signaling beyond histone chaperoning was unknown; PTMA was shown to bind MBD3 and inhibit NuRD/HDAC1-mediated deacetylation, thereby increasing STAT3 acetylation/phosphorylation and driving cardiomyocyte proliferation and cardiac regeneration.\",\n      \"evidence\": \"Reciprocal co-IP, cardiomyocyte-specific Ptma conditional KO, AAV9-mediated overexpression, primary and iPSC-derived cardiomyocyte proliferation assays\",\n      \"pmids\": [\"40408476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether NuRD inhibition is the sole mechanism for PTMA-driven cardiomyocyte proliferation is not established\",\n        \"Domain or region of PTMA mediating MBD3 binding not mapped\",\n        \"Relevance of the PTMA–NuRD axis outside cardiomyocytes not explored\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Whether PTMA has a role in T cell immunity and immunotherapy responses was unknown; PTMA was found to interact with TFAM to preserve mitochondrial DNA integrity and oxidative phosphorylation in CD8 T cells, with TCF1 controlling PTMA expression; T cell–specific Ptma deletion abolished PD-1 blockade efficacy.\",\n      \"evidence\": \"T cell–specific Ptma genetic deletion, PTMA–TFAM interaction assay, mitochondrial function assays, in vivo tumor models with anti-PD-1, transcriptomic analysis of patient CD8 T cells\",\n      \"pmids\": [\"41544148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which PTMA–TFAM interaction preserves mitochondrial DNA integrity is not molecularly defined\",\n        \"Whether nuclear functions of PTMA (H1 chaperoning, NuRD inhibition) also operate in CD8 T cells is untested\",\n        \"Whether PTMA modulates other immune cell types beyond CD8 T cells is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified structural and biochemical framework explaining how the same intrinsically disordered protein executes distinct functions across chromatin (H1 chaperoning, NuRD inhibition) and mitochondria (TFAM/HMGB1 interactions) is lacking.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of PTMA in complex with any of its partners\",\n        \"Whether nuclear vs. mitochondrial functions of PTMA are independently regulated or coordinated is unknown\",\n        \"Relative contribution of each activity to cell proliferation, DNA repair, and immune function in different tissues has not been systematically compared\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [\n      \"NuRD complex (as inhibitory interactor via MBD3)\"\n    ],\n    \"partners\": [\n      \"H1.0\",\n      \"PARP1\",\n      \"MBD3\",\n      \"HDAC1\",\n      \"STAT3\",\n      \"TFAM\",\n      \"HMGB1\",\n      \"TCF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Prothymosin alpha (PTMA) is a highly acidic, intrinsically disordered nuclear protein that couples chromatin remodeling, apoptosis regulation, and metabolic maintenance to cell proliferation and stress responses. PTMA inhibits apoptosome-mediated caspase-9 activation [PMID:12522243], competes with Nrf2 for Keap1 binding to derepress antioxidant gene transcription [PMID:15657435], and forms an ultrahigh-affinity disordered complex with linker histone H1 that enables H1 eviction and PARP1 recruitment at DNA damage sites [PMID:29466338, PMID:40474236]. PTMA also inhibits the MBD3/HDAC1 NuRD deacetylase complex to promote STAT3 acetylation-dependent cardiomyocyte proliferation [PMID:40408476] and interacts with TFAM to maintain mitochondrial DNA integrity and oxidative phosphorylation in CD8 T cells, where its loss abolishes anti-PD-1 therapeutic efficacy [PMID:41544148].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Cloning of PTMA established it as a highly acidic, signal-peptide-lacking nuclear protein whose mRNA is sharply induced by mitogens and serum, linking it to proliferating cells.\",\n      \"evidence\": \"cDNA cloning, Northern blot in mitogen-stimulated lymphocytes and serum-restimulated NIH 3T3 cells\",\n      \"pmids\": [\"3467312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional role defined beyond expression correlation with proliferation\", \"No binding partners identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Biochemical fractionation and RNAi demonstrated that PTMA acts as an endogenous inhibitor of apoptosome formation, directly opposing caspase-9 activation and defining its first molecular mechanism.\",\n      \"evidence\": \"Biochemical fractionation, PETCM chemical genetics, RNAi knockdown, UV-induced apoptosis assay in human cell lines\",\n      \"pmids\": [\"12522243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of apoptosome inhibition not resolved\", \"Relative contribution versus other antiapoptotic factors in vivo unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Two independent studies expanded PTMA's functions beyond apoptosis: one showed PTMA competes with Nrf2 for Keap1 binding to activate antioxidant transcription, while another demonstrated that HuR binding to PTMA mRNA drives its translation to execute HuR's antiapoptotic program.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro competition pulldown, Nrf2 reporter assays (Keap1); RNA immunoprecipitation, polysome profiling, translation-blocking oligomers (HuR–PTMA mRNA)\",\n      \"pmids\": [\"15657435\", \"15861128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Keap1 competition and apoptosome inhibition are coordinated or independent arms of PTMA signaling\", \"Post-translational modifications regulating PTMA–Keap1 interaction unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Biophysical dissection revealed that PTMA and histone H1 form a picomolar-affinity complex in which both proteins remain fully disordered, establishing a charge-driven 'fuzzy' interaction paradigm for intrinsically disordered proteins.\",\n      \"evidence\": \"Single-molecule FRET, NMR, molecular dynamics simulations, isothermal titration calorimetry with purified recombinant proteins\",\n      \"pmids\": [\"29466338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of H1 binding for chromatin biology not yet demonstrated at the time\", \"In vivo relevance of the picomolar affinity not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Co-immunoprecipitation and rescue experiments positioned PTMA upstream of HMGB1 in maintaining mitochondrial oxidative phosphorylation and suppressing ROS in esophageal squamous cell carcinoma cells.\",\n      \"evidence\": \"Co-IP, siRNA knockdown with HMGB1 overexpression rescue, ROS and mitochondrial complex activity assays in ESCC cells\",\n      \"pmids\": [\"37065565\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab observation; independent confirmation needed\", \"Direct versus indirect nature of PTMA–HMGB1 interaction not resolved\", \"Generalizability beyond ESCC unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies converged to establish PTMA as a linker histone chaperone critical for DNA damage repair and as an inhibitor of the MBD3/HDAC1 NuRD complex that drives STAT3-dependent cardiomyocyte proliferation, respectively extending the H1-binding and chromatin-regulatory functions to defined physiological contexts.\",\n      \"evidence\": \"CRISPR Ptma-/- cells with microirradiation live imaging and PARP1 recruitment (DNA repair); conditional cardiomyocyte Ptma KO mice, Co-IP with MBD3, HDAC activity assays, AAV9 rescue (cardiac regeneration)\",\n      \"pmids\": [\"40474236\", \"40408476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H1 chaperone and NuRD inhibition functions are structurally separable within PTMA\", \"Upstream signals controlling PTMA's choice among distinct interactors remain uncharacterized\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Genetic deletion of Ptma from T cells revealed that PTMA sustains mitochondrial DNA integrity via TFAM interaction and is required for CD8 T cell persistence in tumors and for anti-PD-1 therapeutic efficacy, establishing a non-redundant immunometabolic role.\",\n      \"evidence\": \"T cell-specific Ptma KO mice, PD-1 blockade tumor models, Co-IP of PTMA–TFAM, mitochondrial function assays, TCF1 ChIP\",\n      \"pmids\": [\"41544148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PTMA–TFAM interaction occurs in non-immune cells\", \"Structural basis of PTMA–TFAM complex unknown\", \"Contribution of other PTMA functions (apoptosis inhibition, chromatin remodeling) to the T cell phenotype not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PTMA's multiple interaction surfaces—apoptosome inhibition, Keap1 competition, H1 chaperoning, NuRD complex inhibition, and TFAM binding—are coordinately regulated in a single cell remains an open question; no structural or post-translational modification framework integrates these activities.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of any PTMA complex beyond biophysical characterization of the fuzzy H1 interaction\", \"Post-translational modifications (e.g., phosphorylation) that partition PTMA among its partners not systematically mapped\", \"In vivo genetic dissection separating individual PTMA functions not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 8]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 4, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [2, 7]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"complexes\": [\n      \"MBD3/HDAC1 NuRD complex (inhibitory interaction)\"\n    ],\n    \"partners\": [\n      \"H1F0\",\n      \"KEAP1\",\n      \"MBD3\",\n      \"TFAM\",\n      \"HMGB1\",\n      \"ELAVL1\",\n      \"PARP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}